coenzyme q10 Search Results


97
TargetMol amentoflavone secoisolariciresinoldiglucoside honokiol epigallocatechin gallate astragalus polyphenols alphalipoic acid osthole puerarin kakonein
Amentoflavone Secoisolariciresinoldiglucoside Honokiol Epigallocatechin Gallate Astragalus Polyphenols Alphalipoic Acid Osthole Puerarin Kakonein, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+Q10/pmc10348775__jci___133___164660___s048-183-0-31
Average 97 stars, based on 1 article reviews
amentoflavone secoisolariciresinoldiglucoside honokiol epigallocatechin gallate astragalus polyphenols alphalipoic acid osthole puerarin kakonein - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

95
MedChemExpress coq10
Orthogonal Experimental Design and Results of <t> CoQ10-Lip </t>
Coq10, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+Q10/pmc11928442-63-0-6
Average 95 stars, based on 1 article reviews
coq10 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

92
Novus Biologicals human coenzyme q10 coq10 elisa kit elisa kit colorimetric
Orthogonal Experimental Design and Results of <t> CoQ10-Lip </t>
Human Coenzyme Q10 Coq10 Elisa Kit Elisa Kit Colorimetric, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Human+Coenzyme+Q10+(CoQ10)+ELISA+Kit+(Colorimetric)/pm38982045-394-0-8
Average 92 stars, based on 1 article reviews
human coenzyme q10 coq10 elisa kit elisa kit colorimetric - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Cusabio human coq10 elisa kit
TIPE2 regulates ferroptosis-related pathways in THP-1 macrophages following SARS-CoV-2 spike protein stimulation. a , b Expression of ferroptosis-related genes in THP−1 macrophages by qRT-PCR and Western blotting. the ferroptosis-related proteins including GPx4, SLC7A11,FSP1 and ACSL4. Cropped blot is shown for clarity, retaining relevant bands. The uncropped, full-length blot with visible edges is included in Supplementary Figure S3, 4. c Cell viability was evaluated by CCK8 assay in TIPE2-transfected or control THP-1 macrophages treated with S protein alone or in combination with Fer-1 (2µM). d-h Quantification of intracellular levels of ferroptosis-associated metabolic indicators, including ferrous iron (Fe² + ), <t>Coenzyme</t> <t>Q10</t> <t>(CoQ10),</t> NADP⁺/NADPH ratio, malondialdehyde (MDA), and GSH/GSSG ratio in THP-1 macrophages under the indicated treatments. i Representative fluorescence microscopy images showing lipid ROS accumulation in THP-1 macrophages labeled with specific probes. Nuclei are stained blue (Hoechst), lipid ROS appear in green (FITC channel), and merged images are presented. Data are representative of at least three independent experiments. Student’s t-test evaluated differences between two groups, and one-way ANOVA with post-hoc testing (LSD or Tamhane’s T2) was used for comparisons among three groups. (* P < 0.05, ** P < 0.01, *** P < 0.001)
Human Coq10 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Human+Coenzyme+Q10+(CoQ10)+ELISA+Kit/pmc12361446-102-9-13
Average 93 stars, based on 1 article reviews
human coq10 elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Selleck Chemicals coenzyme q10

Coenzyme Q10, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+Q10/pmc11070704-38-0-3
Average 93 stars, based on 1 article reviews
coenzyme q10 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
TLC Pharmaceutical Standards tramadol d6 hydrochloride
Parameters of MS method.
Tramadol D6 Hydrochloride, supplied by TLC Pharmaceutical Standards, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+Q10-d6/pmc08779260-122-3-9
Average 93 stars, based on 1 article reviews
tramadol d6 hydrochloride - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Thermo Fisher coenzyme q10
Parameters of MS method.
Coenzyme Q10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+Q10%2C+98%25/pm34404004-46-3-15
Average 94 stars, based on 1 article reviews
coenzyme q10 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology coenzyme q10
Differential regulation of HCV strains by SPHK2-mediated lipid peroxidation. ( a ) Dose-dependent effects of PUFAs on H77S.3/GLuc and HJ3-5/GLuc RNAs in Huh-7.5 cells. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. ( b ) Growth kinetics of H77S.3/GLuc and HJ3-5/GLuc RNAs in the presence of 50 μM PUFAs. Data shown are mean ± s.e.m. of GLuc activity in supernatant fluids of two replicate cultures. ( c ) Cells transfected with HCV RNAs encoding GLuc were treated with DMSO, 100 μM LA or 100 μM LA plus 1 μM SKI. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. L.O.D. = limit of detection. ( d ) Effect of 1 μM SKI, 1 μM VE, 100 μM <t>CoQ10</t> or 50 μM ARA or DHA, on intracellular malondialdehyde (MDA) abundance in cells transfected with the indicated HCV/GLuc RNAs at 72 h. MDA was significantly increased by PUFAs and reduced by SKI or lipophilic antioxidants ( P < 0.01). ( e ) Analysis of 8-isoprostane abundance in cells electroporated with the indicated HCV RNAs and grown in the presence of 1 μM SKI or VE, or 50 μM LA with or without 1 μM SKI and VE for 48 h. ( f ) Effect of siRNA targeting SPHK isoforms (see ) on MDA accumulation after treatment with increasing concentrations of LA (6.25, 12.5, 25, 50, 100 μM) for 24 h (left panel). MDA levels in Huh-7.5 cells treated with increasing concentrations of LA in the presence of DMSO or 1 μM SKI (right panel). ( g ) Effects of increasing concentrations of VE (left), 1 μM VE alone, or 1 μM VE plus 1 μM SKI (right) on replication of H77S.3/GLuc and HJ3-5/GLuc RNAs. Data shown represent GLuc secreted between 48–72 h relative to DMSO control. ( h ) GLuc secretion from Huh-7.5 cells transfected as in a and treated with 10 μM CuOH with or without 10 μM VE. ( i ) Influence of SKI or VE (each 1 μM) on replication of H77S.3 and HJ3-5 viruses expressing GLuc in cells cultured in the presence or absence of 10% FBS. Medium containing 10% FBS was replaced with FBS-free or 10% FBS media containing SKI, VE or DMSO 6 h after RNA transfection. Data shown represent mean GLuc activity ± s.e.m. from two ( a–f,i ) or three ( g,h ) independent experiments. * P < 0.05, ** P < 0.01.
Coenzyme Q10, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+Q10/pmc04126843-122-9-31
Average 93 stars, based on 1 article reviews
coenzyme q10 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
MedChemExpress hy-n0111
Differential regulation of HCV strains by SPHK2-mediated lipid peroxidation. ( a ) Dose-dependent effects of PUFAs on H77S.3/GLuc and HJ3-5/GLuc RNAs in Huh-7.5 cells. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. ( b ) Growth kinetics of H77S.3/GLuc and HJ3-5/GLuc RNAs in the presence of 50 μM PUFAs. Data shown are mean ± s.e.m. of GLuc activity in supernatant fluids of two replicate cultures. ( c ) Cells transfected with HCV RNAs encoding GLuc were treated with DMSO, 100 μM LA or 100 μM LA plus 1 μM SKI. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. L.O.D. = limit of detection. ( d ) Effect of 1 μM SKI, 1 μM VE, 100 μM <t>CoQ10</t> or 50 μM ARA or DHA, on intracellular malondialdehyde (MDA) abundance in cells transfected with the indicated HCV/GLuc RNAs at 72 h. MDA was significantly increased by PUFAs and reduced by SKI or lipophilic antioxidants ( P < 0.01). ( e ) Analysis of 8-isoprostane abundance in cells electroporated with the indicated HCV RNAs and grown in the presence of 1 μM SKI or VE, or 50 μM LA with or without 1 μM SKI and VE for 48 h. ( f ) Effect of siRNA targeting SPHK isoforms (see ) on MDA accumulation after treatment with increasing concentrations of LA (6.25, 12.5, 25, 50, 100 μM) for 24 h (left panel). MDA levels in Huh-7.5 cells treated with increasing concentrations of LA in the presence of DMSO or 1 μM SKI (right panel). ( g ) Effects of increasing concentrations of VE (left), 1 μM VE alone, or 1 μM VE plus 1 μM SKI (right) on replication of H77S.3/GLuc and HJ3-5/GLuc RNAs. Data shown represent GLuc secreted between 48–72 h relative to DMSO control. ( h ) GLuc secretion from Huh-7.5 cells transfected as in a and treated with 10 μM CuOH with or without 10 μM VE. ( i ) Influence of SKI or VE (each 1 μM) on replication of H77S.3 and HJ3-5 viruses expressing GLuc in cells cultured in the presence or absence of 10% FBS. Medium containing 10% FBS was replaced with FBS-free or 10% FBS media containing SKI, VE or DMSO 6 h after RNA transfection. Data shown represent mean GLuc activity ± s.e.m. from two ( a–f,i ) or three ( g,h ) independent experiments. * P < 0.05, ** P < 0.01.
Hy N0111, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+Q10/pmc12254393-54-0-3
Average 94 stars, based on 1 article reviews
hy-n0111 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Valiant Co Ltd coa trilithium salt
Differential regulation of HCV strains by SPHK2-mediated lipid peroxidation. ( a ) Dose-dependent effects of PUFAs on H77S.3/GLuc and HJ3-5/GLuc RNAs in Huh-7.5 cells. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. ( b ) Growth kinetics of H77S.3/GLuc and HJ3-5/GLuc RNAs in the presence of 50 μM PUFAs. Data shown are mean ± s.e.m. of GLuc activity in supernatant fluids of two replicate cultures. ( c ) Cells transfected with HCV RNAs encoding GLuc were treated with DMSO, 100 μM LA or 100 μM LA plus 1 μM SKI. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. L.O.D. = limit of detection. ( d ) Effect of 1 μM SKI, 1 μM VE, 100 μM <t>CoQ10</t> or 50 μM ARA or DHA, on intracellular malondialdehyde (MDA) abundance in cells transfected with the indicated HCV/GLuc RNAs at 72 h. MDA was significantly increased by PUFAs and reduced by SKI or lipophilic antioxidants ( P < 0.01). ( e ) Analysis of 8-isoprostane abundance in cells electroporated with the indicated HCV RNAs and grown in the presence of 1 μM SKI or VE, or 50 μM LA with or without 1 μM SKI and VE for 48 h. ( f ) Effect of siRNA targeting SPHK isoforms (see ) on MDA accumulation after treatment with increasing concentrations of LA (6.25, 12.5, 25, 50, 100 μM) for 24 h (left panel). MDA levels in Huh-7.5 cells treated with increasing concentrations of LA in the presence of DMSO or 1 μM SKI (right panel). ( g ) Effects of increasing concentrations of VE (left), 1 μM VE alone, or 1 μM VE plus 1 μM SKI (right) on replication of H77S.3/GLuc and HJ3-5/GLuc RNAs. Data shown represent GLuc secreted between 48–72 h relative to DMSO control. ( h ) GLuc secretion from Huh-7.5 cells transfected as in a and treated with 10 μM CuOH with or without 10 μM VE. ( i ) Influence of SKI or VE (each 1 μM) on replication of H77S.3 and HJ3-5 viruses expressing GLuc in cells cultured in the presence or absence of 10% FBS. Medium containing 10% FBS was replaced with FBS-free or 10% FBS media containing SKI, VE or DMSO 6 h after RNA transfection. Data shown represent mean GLuc activity ± s.e.m. from two ( a–f,i ) or three ( g,h ) independent experiments. * P < 0.05, ** P < 0.01.
Coa Trilithium Salt, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Coenzyme+A/10__1158_slash_1535___7163__mct___10___0902-83-19-23
Average 96 stars, based on 1 article reviews
coa trilithium salt - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Chem Impex International glycerol
Differential regulation of HCV strains by SPHK2-mediated lipid peroxidation. ( a ) Dose-dependent effects of PUFAs on H77S.3/GLuc and HJ3-5/GLuc RNAs in Huh-7.5 cells. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. ( b ) Growth kinetics of H77S.3/GLuc and HJ3-5/GLuc RNAs in the presence of 50 μM PUFAs. Data shown are mean ± s.e.m. of GLuc activity in supernatant fluids of two replicate cultures. ( c ) Cells transfected with HCV RNAs encoding GLuc were treated with DMSO, 100 μM LA or 100 μM LA plus 1 μM SKI. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. L.O.D. = limit of detection. ( d ) Effect of 1 μM SKI, 1 μM VE, 100 μM <t>CoQ10</t> or 50 μM ARA or DHA, on intracellular malondialdehyde (MDA) abundance in cells transfected with the indicated HCV/GLuc RNAs at 72 h. MDA was significantly increased by PUFAs and reduced by SKI or lipophilic antioxidants ( P < 0.01). ( e ) Analysis of 8-isoprostane abundance in cells electroporated with the indicated HCV RNAs and grown in the presence of 1 μM SKI or VE, or 50 μM LA with or without 1 μM SKI and VE for 48 h. ( f ) Effect of siRNA targeting SPHK isoforms (see ) on MDA accumulation after treatment with increasing concentrations of LA (6.25, 12.5, 25, 50, 100 μM) for 24 h (left panel). MDA levels in Huh-7.5 cells treated with increasing concentrations of LA in the presence of DMSO or 1 μM SKI (right panel). ( g ) Effects of increasing concentrations of VE (left), 1 μM VE alone, or 1 μM VE plus 1 μM SKI (right) on replication of H77S.3/GLuc and HJ3-5/GLuc RNAs. Data shown represent GLuc secreted between 48–72 h relative to DMSO control. ( h ) GLuc secretion from Huh-7.5 cells transfected as in a and treated with 10 μM CuOH with or without 10 μM VE. ( i ) Influence of SKI or VE (each 1 μM) on replication of H77S.3 and HJ3-5 viruses expressing GLuc in cells cultured in the presence or absence of 10% FBS. Medium containing 10% FBS was replaced with FBS-free or 10% FBS media containing SKI, VE or DMSO 6 h after RNA transfection. Data shown represent mean GLuc activity ± s.e.m. from two ( a–f,i ) or three ( g,h ) independent experiments. * P < 0.05, ** P < 0.01.
Glycerol, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Glycerol/pmc07842297-62-133-134
Average 95 stars, based on 1 article reviews
glycerol - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Shanghai Korain Biotech Co Ltd human hba1c elisa kit
Differential regulation of HCV strains by SPHK2-mediated lipid peroxidation. ( a ) Dose-dependent effects of PUFAs on H77S.3/GLuc and HJ3-5/GLuc RNAs in Huh-7.5 cells. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. ( b ) Growth kinetics of H77S.3/GLuc and HJ3-5/GLuc RNAs in the presence of 50 μM PUFAs. Data shown are mean ± s.e.m. of GLuc activity in supernatant fluids of two replicate cultures. ( c ) Cells transfected with HCV RNAs encoding GLuc were treated with DMSO, 100 μM LA or 100 μM LA plus 1 μM SKI. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. L.O.D. = limit of detection. ( d ) Effect of 1 μM SKI, 1 μM VE, 100 μM <t>CoQ10</t> or 50 μM ARA or DHA, on intracellular malondialdehyde (MDA) abundance in cells transfected with the indicated HCV/GLuc RNAs at 72 h. MDA was significantly increased by PUFAs and reduced by SKI or lipophilic antioxidants ( P < 0.01). ( e ) Analysis of 8-isoprostane abundance in cells electroporated with the indicated HCV RNAs and grown in the presence of 1 μM SKI or VE, or 50 μM LA with or without 1 μM SKI and VE for 48 h. ( f ) Effect of siRNA targeting SPHK isoforms (see ) on MDA accumulation after treatment with increasing concentrations of LA (6.25, 12.5, 25, 50, 100 μM) for 24 h (left panel). MDA levels in Huh-7.5 cells treated with increasing concentrations of LA in the presence of DMSO or 1 μM SKI (right panel). ( g ) Effects of increasing concentrations of VE (left), 1 μM VE alone, or 1 μM VE plus 1 μM SKI (right) on replication of H77S.3/GLuc and HJ3-5/GLuc RNAs. Data shown represent GLuc secreted between 48–72 h relative to DMSO control. ( h ) GLuc secretion from Huh-7.5 cells transfected as in a and treated with 10 μM CuOH with or without 10 μM VE. ( i ) Influence of SKI or VE (each 1 μM) on replication of H77S.3 and HJ3-5 viruses expressing GLuc in cells cultured in the presence or absence of 10% FBS. Medium containing 10% FBS was replaced with FBS-free or 10% FBS media containing SKI, VE or DMSO 6 h after RNA transfection. Data shown represent mean GLuc activity ± s.e.m. from two ( a–f,i ) or three ( g,h ) independent experiments. * P < 0.05, ** P < 0.01.
Human Hba1c Elisa Kit, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coenzyme+q10/Human+Coenzyme+Q10/pm40604045-118-13-18
Average 94 stars, based on 1 article reviews
human hba1c elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


Orthogonal Experimental Design and Results of  CoQ10-Lip

Journal: International Journal of Nanomedicine

Article Title: Aptamer Functionalized Liposomes Co-Loaded with Exenatide-4 and Coenzyme Q10 Ameliorate Type 2 Diabetes Mellitus by Improving Pancreatic β Cell Function

doi: 10.2147/IJN.S510240

Figure Lengend Snippet: Orthogonal Experimental Design and Results of CoQ10-Lip

Article Snippet: CoQ10 and Ext-4 were purchased from Med Chem Express (Guangzhou, China); Phosphatidylcholine (PC), cholesterol (Chol), and streptozotocin (STZ) were purchased from Aladdin Biochemical Technology (Shanghai, China).

Techniques:

Trend chart of factor levels in CoQ10-Lip.

Journal: International Journal of Nanomedicine

Article Title: Aptamer Functionalized Liposomes Co-Loaded with Exenatide-4 and Coenzyme Q10 Ameliorate Type 2 Diabetes Mellitus by Improving Pancreatic β Cell Function

doi: 10.2147/IJN.S510240

Figure Lengend Snippet: Trend chart of factor levels in CoQ10-Lip.

Article Snippet: CoQ10 and Ext-4 were purchased from Med Chem Express (Guangzhou, China); Phosphatidylcholine (PC), cholesterol (Chol), and streptozotocin (STZ) were purchased from Aladdin Biochemical Technology (Shanghai, China).

Techniques:

Characterization of (E+Q)-Lip-Apt (n=3) ( \documentclass[12pt]{minimal} \usepackage{wasysym} \usepackage[substack]{amsmath} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage[mathscr]{eucal} \usepackage{mathrsfs} \DeclareFontFamily{T1}{linotext}{} \DeclareFontShape{T1}{linotext}{m}{n} {linotext }{} \DeclareSymbolFont{linotext}{T1}{linotext}{m}{n} \DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext} \begin{document}$\overline {x } \pm {\ }s$\end{document} )

Journal: International Journal of Nanomedicine

Article Title: Aptamer Functionalized Liposomes Co-Loaded with Exenatide-4 and Coenzyme Q10 Ameliorate Type 2 Diabetes Mellitus by Improving Pancreatic β Cell Function

doi: 10.2147/IJN.S510240

Figure Lengend Snippet: Characterization of (E+Q)-Lip-Apt (n=3) ( \documentclass[12pt]{minimal} \usepackage{wasysym} \usepackage[substack]{amsmath} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage[mathscr]{eucal} \usepackage{mathrsfs} \DeclareFontFamily{T1}{linotext}{} \DeclareFontShape{T1}{linotext}{m}{n} {linotext }{} \DeclareSymbolFont{linotext}{T1}{linotext}{m}{n} \DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext} \begin{document}$\overline {x } \pm {\ }s$\end{document} )

Article Snippet: CoQ10 and Ext-4 were purchased from Med Chem Express (Guangzhou, China); Phosphatidylcholine (PC), cholesterol (Chol), and streptozotocin (STZ) were purchased from Aladdin Biochemical Technology (Shanghai, China).

Techniques: Zeta Potential Analyzer

Factor Levels of  CoQ10-Lip

Journal: International Journal of Nanomedicine

Article Title: Aptamer Functionalized Liposomes Co-Loaded with Exenatide-4 and Coenzyme Q10 Ameliorate Type 2 Diabetes Mellitus by Improving Pancreatic β Cell Function

doi: 10.2147/IJN.S510240

Figure Lengend Snippet: Factor Levels of CoQ10-Lip

Article Snippet: CoQ10 and Ext-4 were purchased from Med Chem Express (Guangzhou, China); Phosphatidylcholine (PC), cholesterol (Chol), and streptozotocin (STZ) were purchased from Aladdin Biochemical Technology (Shanghai, China).

Techniques:

TIPE2 regulates ferroptosis-related pathways in THP-1 macrophages following SARS-CoV-2 spike protein stimulation. a , b Expression of ferroptosis-related genes in THP−1 macrophages by qRT-PCR and Western blotting. the ferroptosis-related proteins including GPx4, SLC7A11,FSP1 and ACSL4. Cropped blot is shown for clarity, retaining relevant bands. The uncropped, full-length blot with visible edges is included in Supplementary Figure S3, 4. c Cell viability was evaluated by CCK8 assay in TIPE2-transfected or control THP-1 macrophages treated with S protein alone or in combination with Fer-1 (2µM). d-h Quantification of intracellular levels of ferroptosis-associated metabolic indicators, including ferrous iron (Fe² + ), Coenzyme Q10 (CoQ10), NADP⁺/NADPH ratio, malondialdehyde (MDA), and GSH/GSSG ratio in THP-1 macrophages under the indicated treatments. i Representative fluorescence microscopy images showing lipid ROS accumulation in THP-1 macrophages labeled with specific probes. Nuclei are stained blue (Hoechst), lipid ROS appear in green (FITC channel), and merged images are presented. Data are representative of at least three independent experiments. Student’s t-test evaluated differences between two groups, and one-way ANOVA with post-hoc testing (LSD or Tamhane’s T2) was used for comparisons among three groups. (* P < 0.05, ** P < 0.01, *** P < 0.001)

Journal: Scientific Reports

Article Title: TIPE2 suppresses ferroptosis and pro-inflammatory polarization in macrophages triggered by SARS-CoV-2 spike protein

doi: 10.1038/s41598-025-14235-1

Figure Lengend Snippet: TIPE2 regulates ferroptosis-related pathways in THP-1 macrophages following SARS-CoV-2 spike protein stimulation. a , b Expression of ferroptosis-related genes in THP−1 macrophages by qRT-PCR and Western blotting. the ferroptosis-related proteins including GPx4, SLC7A11,FSP1 and ACSL4. Cropped blot is shown for clarity, retaining relevant bands. The uncropped, full-length blot with visible edges is included in Supplementary Figure S3, 4. c Cell viability was evaluated by CCK8 assay in TIPE2-transfected or control THP-1 macrophages treated with S protein alone or in combination with Fer-1 (2µM). d-h Quantification of intracellular levels of ferroptosis-associated metabolic indicators, including ferrous iron (Fe² + ), Coenzyme Q10 (CoQ10), NADP⁺/NADPH ratio, malondialdehyde (MDA), and GSH/GSSG ratio in THP-1 macrophages under the indicated treatments. i Representative fluorescence microscopy images showing lipid ROS accumulation in THP-1 macrophages labeled with specific probes. Nuclei are stained blue (Hoechst), lipid ROS appear in green (FITC channel), and merged images are presented. Data are representative of at least three independent experiments. Student’s t-test evaluated differences between two groups, and one-way ANOVA with post-hoc testing (LSD or Tamhane’s T2) was used for comparisons among three groups. (* P < 0.05, ** P < 0.01, *** P < 0.001)

Article Snippet: Intracellular coenzyme (Co) Q10 levels were determined using a human CoQ10 ELISA kit (CUSABIO, China).

Techniques: Expressing, Quantitative RT-PCR, Western Blot, CCK-8 Assay, Transfection, Control, Fluorescence, Microscopy, Labeling, Staining

Journal: iScience

Article Title: Phospholipase PLA2G7 is complementary to GPX4 in mitigating punicic-acid-induced ferroptosis in prostate cancer cells

doi: 10.1016/j.isci.2024.109774

Figure Lengend Snippet:

Article Snippet: Coenzyme Q10 , Selleck chemicals , Cat# S2398.

Techniques: Virus, Control, Expressing, Plasmid Preparation, Recombinant, Western Blot, Transfection, Saline, Protease Inhibitor, cDNA Synthesis, Bicinchoninic Acid Protein Assay, Software, RNA Sequencing

Parameters of MS method.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Parameters of MS method.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques:

The 90% confidence intervals for the stability calculated according to for ( a ) tramadol and ( b ) O-desmethyl-tramadol in human plasma stored at room temperature for 24 h and 72 h. Each sample size is associated with a different color, with light color indicating low concentration and dark color indicating high concentration. Vertical dashed lines indicate stability limits of 85–115%.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: The 90% confidence intervals for the stability calculated according to for ( a ) tramadol and ( b ) O-desmethyl-tramadol in human plasma stored at room temperature for 24 h and 72 h. Each sample size is associated with a different color, with light color indicating low concentration and dark color indicating high concentration. Vertical dashed lines indicate stability limits of 85–115%.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Descriptive statistics for the width [%] of a 90% confidence interval. The number of pairs is the equal number of reference and study samples.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Descriptive statistics for the width [%] of a 90% confidence interval. The number of pairs is the equal number of reference and study samples.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques:

Width of a 90% confidence interval for stability calculated according to for tramadol (full color) and O-desmethyl-tramadol (striped color) in human plasma stored at room temperature for 24 h and 72 h for each sample size: ( a ) low concentration, ( b ) high concentration.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Width of a 90% confidence interval for stability calculated according to for tramadol (full color) and O-desmethyl-tramadol (striped color) in human plasma stored at room temperature for 24 h and 72 h for each sample size: ( a ) low concentration, ( b ) high concentration.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Post-hoc least significant difference test (Fisher’s LSD test). Vertical bars means a 90% confidence interval: ( a ) tramadol; ( b ) O-desmethyl-tramadol. On each plot, light color indicates low concentration and dark color indicates high concentration.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Post-hoc least significant difference test (Fisher’s LSD test). Vertical bars means a 90% confidence interval: ( a ) tramadol; ( b ) O-desmethyl-tramadol. On each plot, light color indicates low concentration and dark color indicates high concentration.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Concentrations of  tramadol  in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 15.0 ng/mL) and high QC (nominal concentration of 600 ng/mL).

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Concentrations of tramadol in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 15.0 ng/mL) and high QC (nominal concentration of 600 ng/mL).

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Concentrations of O-desmethyl  tramadol  in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 7.50 ng/mL) and high QC (nominal concentration of 120 ng/mL).

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Concentrations of O-desmethyl tramadol in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 7.50 ng/mL) and high QC (nominal concentration of 120 ng/mL).

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Differential regulation of HCV strains by SPHK2-mediated lipid peroxidation. ( a ) Dose-dependent effects of PUFAs on H77S.3/GLuc and HJ3-5/GLuc RNAs in Huh-7.5 cells. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. ( b ) Growth kinetics of H77S.3/GLuc and HJ3-5/GLuc RNAs in the presence of 50 μM PUFAs. Data shown are mean ± s.e.m. of GLuc activity in supernatant fluids of two replicate cultures. ( c ) Cells transfected with HCV RNAs encoding GLuc were treated with DMSO, 100 μM LA or 100 μM LA plus 1 μM SKI. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. L.O.D. = limit of detection. ( d ) Effect of 1 μM SKI, 1 μM VE, 100 μM CoQ10 or 50 μM ARA or DHA, on intracellular malondialdehyde (MDA) abundance in cells transfected with the indicated HCV/GLuc RNAs at 72 h. MDA was significantly increased by PUFAs and reduced by SKI or lipophilic antioxidants ( P < 0.01). ( e ) Analysis of 8-isoprostane abundance in cells electroporated with the indicated HCV RNAs and grown in the presence of 1 μM SKI or VE, or 50 μM LA with or without 1 μM SKI and VE for 48 h. ( f ) Effect of siRNA targeting SPHK isoforms (see ) on MDA accumulation after treatment with increasing concentrations of LA (6.25, 12.5, 25, 50, 100 μM) for 24 h (left panel). MDA levels in Huh-7.5 cells treated with increasing concentrations of LA in the presence of DMSO or 1 μM SKI (right panel). ( g ) Effects of increasing concentrations of VE (left), 1 μM VE alone, or 1 μM VE plus 1 μM SKI (right) on replication of H77S.3/GLuc and HJ3-5/GLuc RNAs. Data shown represent GLuc secreted between 48–72 h relative to DMSO control. ( h ) GLuc secretion from Huh-7.5 cells transfected as in a and treated with 10 μM CuOH with or without 10 μM VE. ( i ) Influence of SKI or VE (each 1 μM) on replication of H77S.3 and HJ3-5 viruses expressing GLuc in cells cultured in the presence or absence of 10% FBS. Medium containing 10% FBS was replaced with FBS-free or 10% FBS media containing SKI, VE or DMSO 6 h after RNA transfection. Data shown represent mean GLuc activity ± s.e.m. from two ( a–f,i ) or three ( g,h ) independent experiments. * P < 0.05, ** P < 0.01.

Journal: Nature medicine

Article Title: Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation

doi: 10.1038/nm.3610

Figure Lengend Snippet: Differential regulation of HCV strains by SPHK2-mediated lipid peroxidation. ( a ) Dose-dependent effects of PUFAs on H77S.3/GLuc and HJ3-5/GLuc RNAs in Huh-7.5 cells. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. ( b ) Growth kinetics of H77S.3/GLuc and HJ3-5/GLuc RNAs in the presence of 50 μM PUFAs. Data shown are mean ± s.e.m. of GLuc activity in supernatant fluids of two replicate cultures. ( c ) Cells transfected with HCV RNAs encoding GLuc were treated with DMSO, 100 μM LA or 100 μM LA plus 1 μM SKI. Data shown represent percent GLuc activity secreted between 48–72 h relative to DMSO control. L.O.D. = limit of detection. ( d ) Effect of 1 μM SKI, 1 μM VE, 100 μM CoQ10 or 50 μM ARA or DHA, on intracellular malondialdehyde (MDA) abundance in cells transfected with the indicated HCV/GLuc RNAs at 72 h. MDA was significantly increased by PUFAs and reduced by SKI or lipophilic antioxidants ( P < 0.01). ( e ) Analysis of 8-isoprostane abundance in cells electroporated with the indicated HCV RNAs and grown in the presence of 1 μM SKI or VE, or 50 μM LA with or without 1 μM SKI and VE for 48 h. ( f ) Effect of siRNA targeting SPHK isoforms (see ) on MDA accumulation after treatment with increasing concentrations of LA (6.25, 12.5, 25, 50, 100 μM) for 24 h (left panel). MDA levels in Huh-7.5 cells treated with increasing concentrations of LA in the presence of DMSO or 1 μM SKI (right panel). ( g ) Effects of increasing concentrations of VE (left), 1 μM VE alone, or 1 μM VE plus 1 μM SKI (right) on replication of H77S.3/GLuc and HJ3-5/GLuc RNAs. Data shown represent GLuc secreted between 48–72 h relative to DMSO control. ( h ) GLuc secretion from Huh-7.5 cells transfected as in a and treated with 10 μM CuOH with or without 10 μM VE. ( i ) Influence of SKI or VE (each 1 μM) on replication of H77S.3 and HJ3-5 viruses expressing GLuc in cells cultured in the presence or absence of 10% FBS. Medium containing 10% FBS was replaced with FBS-free or 10% FBS media containing SKI, VE or DMSO 6 h after RNA transfection. Data shown represent mean GLuc activity ± s.e.m. from two ( a–f,i ) or three ( g,h ) independent experiments. * P < 0.05, ** P < 0.01.

Article Snippet: Vitamin E (α-, rac-β-, and γ-tocopherols), 4-deoxypyridoxine hydrochloride (DOP), coenzyme Q10, butylated hydroxytoluene, N-acetyl-L-cysteine, diphenyleneiodonium chloride, oleic acid, and cyclosporine A were from Sigma-Aldrich. nSMase spiroepoxide and cumene hydroperoxide were from Santa Cruz Biotechnology, D609 was from Enzo Life Sciences, and sofosbuvir (PSI-7977) was from Chemscene.

Techniques: Activity Assay, Control, Transfection, Expressing, Cell Culture